| abstract |
The presently disclosed subject matter provides high-throughput assays, e.g, yeast three-hybrid assays, for detecting the presence of a molecule, e.g, therapeutic molecule. In certain embodiments, the presently disclosed subject matter provides genetically-engineered cells and assays for detecting tetracycline or derivatives thereof and kits for performing such assays. |